GILEAD SCIENCES DENMARK ApS: Financial statements 2024
CVR: 30899032
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
GILEAD SCIENCES DENMARK ApS (CVR 30899032) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 174,279,220 and a net result of DKK 5,860,294 compared with DKK 3,207,507 the year before. That is an increase of 58.6% compared with the year before. The profit margin was 3.4%. Equity in the 2024 report amounted to DKK 59,988,214. The solvency ratio was 59.2%. The company had 10 employees in the financial year.
- Revenue
- DKK 174,279,220
- Gross Profit
- DKK 21,824,130
- Profit/Loss
- DKK 5,860,294
- Equity
- DKK 59,988,214
- Total Assets
- DKK 101,309,355
- Employees
- 10
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 174.3 mio. | 21.8 mio. | 5.9 mio. | 60 mio. | 10 |
| 2023 | 109.9 mio. | 22.7 mio. | 3.2 mio. | 54.1 mio. | 13 |
| 2022 | 228.4 mio. | 27.5 mio. | 5.3 mio. | 50.9 mio. | 12 |
| 2021 | 174.8 mio. | 28 mio. | 3.9 mio. | 45.6 mio. | 13 |
| 2020 | 150.7 mio. | 28 mio. | 3.8 mio. | 41.7 mio. | 13 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of December 20, 2024, Clemens Schödl has stepped down as adm. dir. of GILEAD SCIENCES DENMARK ApS.
GILEAD SCIENCES DENMARK ApS has won the tender "Amgros 2024 1.1059.b" issued by Amgros I/S worth 2,750,000 DKK.
GILEAD SCIENCES DENMARK ApS has won the tender "Amgros 2024 1.473.a" issued by Amgros I/S worth 5,780,000 DKK.
GILEAD SCIENCES DENMARK ApS has published its annual report for 2023. Revenue came to DKK 109,907,440, and the net result was DKK 3,207,507.
GILEAD SCIENCES DENMARK ApS has won the tender "Amgros 2024 1.472.a" issued by Amgros I/S worth 20,675,200,000 DKK.
GILEAD SCIENCES DENMARK ApS has won the tender "Amgros 2024 1.402.a" issued by Amgros I/S worth 3,660,000 DKK.
About GILEAD SCIENCES DENMARK ApS
GILEAD SCIENCES DENMARK ApS is a Danish company of the type Anpartsselskab based in Frederiksberg C, founded in 2007. The company is registered under the industry Agenturhandel med specialiseret varesortiment, bortset fra køretøjer. The management consists of Pau Arbos Vila, Anna Sophia Melén and Helene Annika Oscarsson. The board consists of Hans York-Julian Stücker (chair), Josephine Yang Comiskey and Juan Peche Marín-Lázaro. The company is owned by Gilead Sciences Ireland UC. The company has 11 employees (2018). In 2025, the company reported revenue of DKK 186,763,801 and a net result of DKK 5,145,834 compared with DKK 5,860,294 the year before. Equity in the 2025 report amounted to DKK 65,134,048.